Tempest Therapeutics, Inc. Restricted Cash, Current
Tempest Therapeutics, Inc. (TPST) had Restricted Cash, Current of $450.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Cash Equivalent, Current
us-gaap:RestrictedCashCurrent · last filed 2023-11-08
- 2023-03-31: Restricted Cash, Current $450.00K.
- 2022-12-31: Restricted Cash, Current $450.00K.
- 2022-09-30: Restricted Cash, Current $15.20M.
- 2022-06-30: Restricted Cash, Current $15.00M.
| Period end | Restricted Cash, Current | Restricted Cash, Current as first filed |
|---|---|---|
| 2023-03-31 | $450.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $450.00K 10-Q · filed 2023-11-08 | |
| 2022-09-30 | $15.20M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $15.00M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $15.00M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $15.00M 10-Q · filed 2022-11-08 | |
| 2021-09-30 | $45.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $45.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $15.00M 10-Q · filed 2022-05-13 | $45.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $0.00 10-Q · filed 2021-08-12 | $484.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $540.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $705.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $870.00K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.03M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $703.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $699.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $45.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $45.00K 10-K · filed 2020-03-11 | |
| 2018-09-30 | $789.00K 10-Q · filed 2018-11-09 | |
| 2017-12-31 | $45.00K 10-K · filed 2019-04-01 | $0.00 10-Q · filed 2018-11-09 |
| 2017-09-30 | $789.00K 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |